Current Drug Targets
Volume 21, 16 Issues, 2020
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
  |
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Most Cited Articles
Review Article
Cyclin-dependent kinase 2 in cellular senescence and cancer. A structural and functional review
, 2019; 20(7): 716-726.Priscylla Andrade Volkart, Gabriela Bitencourt-Ferreira, André Arigony Souto* and Walter Filgueira de Azevedo *
DOI: 10.2174/1389450120666181204165344
Review Article
CDK9 as an appealing target for therapeutic interventions
, 2019; 20(4): 453-464.Shirin Eyvazi, Mohammad Saeid Hejazi, Homan Kahroba, Mozghan Abasi, Reza Eghdam Zamiri and Vahideh Tarhriz*
DOI: 10.2174/1389450119666181026152221
Review Article
Molecular docking: Challenges, advances and its use in drug discovery perspective
, 2019; 20(5): 501-521.Surovi Saikia and Manobjyoti Bordoloi*
DOI: 10.2174/1389450119666181022153016
Review Article
Functional diversity of quorum sensing receptors in pathogenic bacteria: Interspecies, intraspecies and interkingdom level
, 2019; 20(6): 655-667.Fazlurrahman Khan, Aqib Javaid and Young-Mog Kim*
DOI: 10.2174/1389450120666181123123333
Review Article
Celecoxib in cancer therapy and prevention - review
, 2019; 20(3): 302-315.Natalia Tołoczko-Iwaniuk , Dorota Dziemiańczyk-Pakieła, Beata Klaudia Nowaszewska, Katarzyna Celińska-Janowicz and Wojciech Miltyk*
DOI: 10.2174/1389450119666180803121737
Review Article
Exosomes in therapy: Engineering, pharmacokinetics and future applications
, 2019; 20(1): 87-95.Claudia Arenaccio, Chiara Chiozzini, Flavia Ferrantelli, Patrizia Leone, Eleonora Olivetta and Maurizio Federico*
DOI: 10.2174/1389450119666180521100409
Review Article
High mobility group box-1 (HMGB1): A potential target in therapeutics
, 2019; 20(14): 1474-1485.Eyaldeva C. Vijayakumar, Lokesh Kumar Bhatt* and Kedar S. Prabhavalkar
DOI: 10.2174/1389450120666190618125100
Review Article
PI3K/ AKT/ mTOR pathway as a therapeutic target for colorectal cancer: A review of preclinical and clinical evidence
, 2019; 20(12): 1217-1226.Arunaksharan Narayanankutty*
DOI: 10.2174/1389450120666190618123846
Review Article
Silicon quantum dots: Promising theranostic probes for the future
, 2019; 20(12): 1255-1263.Vishnu Sankar Sivasankarapillai, Jobin Jose, Muhammad Salman Shanavas, Akash Marathakam, Md. Sahab Uddin and Bijo Mathew*
DOI: 10.2174/1389450120666190405152315
Review Article
Essential oils: An impending substitute of synthetic antimicrobial agents to overcome antimicrobial resistance
, 2019; 20(6): 605-624.Rajinder Pal Mittal, Abhilash Rana and Vikas Jaitak*
DOI: 10.2174/1389450119666181031122917
Review Article
A survey for predicting enzyme family classes using machine learning methods
, 2019; 20(5): 540-550.Jiu-Xin Tan, Hao Lv, Fang Wang, Fu-Ying Dao, Wei Chen* and Hui Ding*
DOI: 10.2174/1389450119666181002143355
Review Article
Do the natural chemical compounds interact with the same targets of current pharmacotherapy for weight management?-A review
, 2019; 20(4): 399-411.Shiqi Luo, George Binh Lenon*, Harsharn Gill, Heidi Yuen, Angela Wei Hong Yang, Andrew Hung and Linh Toan Nguyen
DOI: 10.2174/1389450119666180830125958
Review Article
Inhibition of RAGE axis signaling: A pharmacological challenge
, 2019; 20(3): 340-346.Armando Rojas*, Miguel Morales, Ileana Gonzalez and Paulina Araya
DOI: 10.2174/1389450119666180820105956
Review Article
Advances in discovery of PDE10A inhibitors for CNS-related Disorders. Part 1: Overview of the chemical and biological research
, 2019; 20(1): 122-143.Agnieszka Jankowska, Artur Świerczek, Elżbieta Wyska, Alicja Gawalska, Adam Bucki, Maciej Pawłowski and Grażyna Chłoń-Rzepa*
DOI: 10.2174/1389450119666180808105056
Review Article
Helenalin - A sesquiterpene lactone with multidirectional activity
, 2019; 20(4): 444-452.Joanna Drogosz and Anna Janecka*
DOI: 10.2174/1389450119666181012125230
Editor-in-Chief
Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)
View Full Editorial Board
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
View Full Editorial Board
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.63
Advertisement
Webmaster Contact: info@benthamscience.net